Tocotrienol (SIPP-T3)

tocotrienol · H. Lee Moffitt Cancer Center and Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tocotrienol (SIPP-T3), covering 2025-11-13 to 2025-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) [Phase 2]